Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Microbiol ; 176(5): 370-6, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11702079

ABSTRACT

The uptake of hexose 6-phosphates in Escherichia coli is mediated by the transporter UhpT, the synthesis of which is induced by the presence of glucose 6-phosphate (glucose 6-P) in the medium. Since this protein functions as an anion exchanger, it is generally assumed to be geared for the use of sugar phosphates as a carbon source. However, the question was unresolved whether this transporter can also provide the cells with glucose 6-P as a phosphate source. It is demonstrated in this work that UhpT-mediated glucose 6-P uptake does not allow the cells to grow on glucose 6-P as phosphate source. Hence, the expression of UhpT under phosphate limitation would not be particularly advantageous and some form of interaction between the uhp system and the Pi-limitation-inducible pho regulon, the products of which are involved in phosphate acquisition, may be anticipated. Indeed, the use of an uhpT-lacZ fusion revealed that much higher concentrations of the inducer glucose 6-P were required to elevate uhpT transcription when the pho regulon was expressed. This interference was the result of degradation of glucose 6-P by one of the products of the pho regulon, the periplasmic enzyme alkaline phosphatase. The specific form of interaction between the Pho and Uhp systems is designated inducer degradation.


Subject(s)
Escherichia coli Proteins/genetics , Escherichia coli/metabolism , Gene Expression Regulation, Bacterial , Monosaccharide Transport Proteins/genetics , Phosphates/metabolism , Regulon/physiology , Alkaline Phosphatase/metabolism , Down-Regulation/physiology , Escherichia coli/genetics , Escherichia coli/growth & development , Escherichia coli Proteins/metabolism , Glucose-6-Phosphate/metabolism , Monosaccharide Transport Proteins/metabolism , Mutation
2.
J Bacteriol ; 183(19): 5768-71, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11544243

ABSTRACT

Disruption of pstS encoding the P(i)-binding protein in Escherichia coli generally leads to the constitutive expression of the pho regulon. We demonstrate that P(i)-controlled expression is restored when the activity of the P(i) transporter PitA or PitB is increased. Apparently, PstS is not an essential component of the signal transduction pathway.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Carrier Proteins/metabolism , Escherichia coli Proteins , Escherichia coli/metabolism , Gene Expression Regulation, Bacterial , Periplasmic Binding Proteins , Phosphates/metabolism , Regulon/physiology , ATP-Binding Cassette Transporters/genetics , Carrier Proteins/genetics , Escherichia coli/genetics , Phosphate-Binding Proteins , Signal Transduction
3.
J Bacteriol ; 183(16): 4914-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11466297

ABSTRACT

We have tested the hypothesis that the autoamplification of two-component regulatory systems results in "learning" behavior, i.e., that bacteria respond faster or more extensively to a signal when a similar signal has been perceived in the past. Indeed, the induction of alkaline phosphatase activity upon phosphate limitation was faster if the cultures had been limited for phosphate previously, and this faster response correlated with the autoamplification of the cognate two-component system.


Subject(s)
Escherichia coli/physiology , Phosphates/metabolism , Regulon , Signal Transduction/physiology , Acclimatization , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Escherichia coli/genetics , Escherichia coli/growth & development , Kinetics , Learning , Protein Kinases/metabolism , Time Factors , Transcription Factors/genetics , Transcription Factors/metabolism
4.
J Bacteriol ; 183(15): 4659-63, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11443103

ABSTRACT

Two systems for the uptake of inorganic phosphate (P(i)) in Escherichia coli, PitA and Pst, have been described. A revertant of a pitA pstS double mutant that could grow on P(i) was isolated. We demonstrate that the expression of a new P(i) transporter, PitB, is activated in this strain by a gene amplification event.


Subject(s)
Bacterial Proteins/metabolism , Carrier Proteins/metabolism , Escherichia coli Proteins , Periplasmic Binding Proteins , Phosphates/metabolism , ATP-Binding Cassette Transporters/genetics , Bacterial Proteins/genetics , Base Sequence , Carrier Proteins/genetics , DNA, Bacterial , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Amplification , Genes, Bacterial , Molecular Sequence Data , Mutagenesis , Phosphate-Binding Proteins
5.
Biochim Biophys Acta ; 1385(1): 1-6, 1998 Jun 11.
Article in English | MEDLINE | ID: mdl-9630474

ABSTRACT

The photoactive yellow protein (pyp) gene has been isolated from Rhodobacter sphaeroides by probing with a homologous PCR-product. A sequence analysis shows that this pyp gene encodes a 124 AA protein with 48% identity to the three known PYPs. Downstream from pyp, a number of adjacent open reading frames were identified, including a gene encoding a CoA-ligase homologue (pCL). This latter protein is proposed to be involved in PYP chromophore activation, required for attachment to the apoprotein. We have demonstrated the presence of the chromophoric group, previously identified in PYP from Ectothiorhodospira halophila as trans 4-hydroxy cinnamic acid, in phototrophically cultured R. sphaeroides cells by capillary zone electrophoresis. The basic structure of the chromophore binding pocket in PYP has been conserved, as shown by a 3D model of R. sphaeroides PYP, constructed by homology-based molecular modelling. In addition, this model shows that R. sphaeroides PYP contains a characteristic, positively charged patch.


Subject(s)
Bacterial Proteins , Coumaric Acids/chemistry , Models, Molecular , Photoreceptors, Microbial , Protein Conformation , Rhodobacter sphaeroides/metabolism , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Electrophoresis, Capillary , Molecular Sequence Data , Polymerase Chain Reaction , Propionates , Sequence Alignment
6.
EMBO J ; 15(13): 3209-18, 1996 Jul 01.
Article in English | MEDLINE | ID: mdl-8670821

ABSTRACT

Photoactive yellow protein (PYP) is a photoreceptor that has been isolated from three halophilic phototrophic purple bacteria. The PYP from Ectothiorhodospira halophila BN9626 is the only member for which the sequence has been reported at the DNA level. Here we describe the cloning and sequencing of the genes encoding the PYPs from E.halophila SL-1 (type strain) and Rhodospirillum salexigens. The latter protein contains, like the E.halophila PYP, the chromophore trans p-coumaric acid, as we show here with high performance capillary zone electrophoresis. Additionally, we present evidence for the presence of a gene encoding a PYP homolog in Rhodobacter sphaeroides, the first genetically well-characterized bacterium in which this photoreceptor has been identified. An ORF downstream of the pyp gene from E.halophila encodes an enzyme, which is proposed to be involved in the biosynthesis of the chromophore of PYP. The pyp gene from E.halophila was used for heterologous overexpression in both Escherichia coli and R.sphaeroides, aimed at the development of a holoPYP overexpression system (an intact PYP, containing the p-coumaric acid chromophore and displaying the 446 nm absorbance band). In both organisms the protein could be detected immunologically, but its yellow color was not observed. Molecular genetic construction of a histidine-tagged version of PYP led to its 2500-fold overproduction in E.coli and simplified purification of the heterologously produced apoprotein. HoloPYP could be reconstituted by the addition of p-coumaric anhydride to the histidine-tagged apoPYP (PYP lacking its chromophore). We propose to call the family of photoactive yellow proteins the xanthopsins, in analogy with the rhodopsins.


Subject(s)
Bacterial Proteins/genetics , Chromatiaceae/genetics , Photoreceptors, Microbial , Rhodospirillum/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Bacterial , Molecular Sequence Data , Sequence Homology, Amino Acid
8.
Am J Clin Oncol ; 7(3): 199-204, 1984 Jun.
Article in English | MEDLINE | ID: mdl-6203398

ABSTRACT

Twenty-one male patients with previously untreated advanced squamous cell carcinoma of the head and neck were treated with an induction regimen of bleomycin 15 mg/m2 I.V. bolus followed by a continuous 24-hour I.V. infusion at a dose of 15 mg/m2/day for 7 days. One week following induction therapy, patients were reevaluated for response and then received definitive therapy with surgery and/or radiation therapy. The chemotherapy yielded a major response rate of 33% (one CR, six PR). Toxic manifestations of this regimen were mild, consisting of fever, alopecia, rash, and mucositis. There was no pulmonary toxicity detected. The response rate obtained with bleomycin infusion is inferior to the combination of cis-platinum with a bleomycin infusion as induction therapy in previously untreated patients with squamous cell carcinoma of the head and neck.


Subject(s)
Bleomycin/therapeutic use , Head and Neck Neoplasms/drug therapy , Adult , Aged , Combined Modality Therapy , Drug Evaluation , Follow-Up Studies , Head and Neck Neoplasms/radiotherapy , Head and Neck Neoplasms/surgery , Humans , Infusions, Parenteral , Injections, Intravenous , Male , Middle Aged , Neoplasm Recurrence, Local
9.
Am J Clin Oncol ; 6(3): 301-4, 1983 Jun.
Article in English | MEDLINE | ID: mdl-6846248

ABSTRACT

Sixteen patients with advanced squamous cell carcinoma of the head and neck were treated with a 48-hour I.V. vindesine infusion. The dosage was 3 mg/m2/48 hours every 2 weeks. Toxicity consisted of leukopenia, paresthesias, and phlebitis. Major objective responses were seen in four patients (one CR, three PR), with a median duration of 4 months.


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Head and Neck Neoplasms/drug therapy , Vinblastine/analogs & derivatives , Aged , Antineoplastic Agents/therapeutic use , Drug Evaluation , Female , Humans , Infusions, Parenteral , Male , Middle Aged , Vinblastine/administration & dosage , Vinblastine/therapeutic use , Vindesine
SELECTION OF CITATIONS
SEARCH DETAIL
...